MeSH tree: C17.800.859.675
A research team from South Korea has revealed the specific mechanisms behind the onset of psoriasis by combining large-scale genomic data from more than 1.1 million people with advanced single-cell analysis technology. The ...
10 hours ago
0
2
A study initiated by the European Spondyloarthritis Research Collaboration Network (EuroSpA) examined whether patients' countries of residence are associated with the severity of their psoriatic arthritis (PsA) or axial spondyloarthritis ...
Aug 11, 2026
0
2
Researchers at VIB and KU Leuven, together with international collaborators, have discovered that blocking autophagy—the body's natural recycling system for worn-out cell components—in specialized blood vessels can reduce ...
Jul 28, 2026
0
5
Individuals with psoriasis have a higher burden of myocardial dysfunction, independent of cardiometabolic risk, according to a study published online July 17 in the Journal of the European Academy of Dermatology and Venereology.
Jul 23, 2026
0
6
Psoriasis is a chronic inflammatory skin disease affecting more than 60 million people worldwide, characterized by painful red patches, scaling and skin thickening. While existing biologic treatments largely focus on calming ...
Jul 22, 2026
0
6
Individuals across racial and ethnic groups report psoriasis as a considerable burden, including transportation barriers, difficulty accessing medications and delayed care, according to a study published online July 15 in ...
Jul 20, 2026
0
2
Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine the results for overlooked drug targets for psoriasis. They found ...
Jul 8, 2026
0
12
Stress, bad weather, strep throat, alcohol or cuts—there are a number of triggers that can set off psoriasis. At the same time, a great deal is happening in research on this skin disease, and new ways of controlling the immune ...
Jul 6, 2026
0
3
Higher psoriasis (PsO) disease activity is independently associated with impairment in specific sleep domains, but not global sleep quality, according to a study published online May 29 in the Journal of Clinical Medicine.
Jun 23, 2026
0
8
GLP-1 receptor agonists are currently among the most widely discussed classes of drugs worldwide. They have gained popularity for their effectiveness in treating type 2 diabetes and obesity, but increasing evidence suggests ...
Jun 17, 2026
0
7
